Epigenetic regulation of MIR145 core promoter controls miR-143/145 cluster in bladder cancer progression and treatment outcome
Owing to its highly heterogeneous molecular landscape, bladder cancer (BlCa) is still characterized by non-personalized treatment and lifelong surveillance. Motivated by our previous findings on miR-143/145 value in disease prognosis, we have studied the underlying epigenetic regulation of the miR-1...
Main Authors: | Katerina-Marina Pilala, Maria-Alexandra Papadimitriou, Konstantina Panoutsopoulou, Petros Barbarigos, Panagiotis Levis, Georgios Kotronopoulos, Konstantinos Stravodimos, Andreas Scorilas, Margaritis Avgeris |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-12-01
|
Series: | Molecular Therapy: Nucleic Acids |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2162253122002670 |
Similar Items
-
tRNA-Derived Fragments (tRFs) in Bladder Cancer: Increased 5′-tRF-LysCTT Results in Disease Early Progression and Patients’ Poor Treatment Outcome
by: Maria-Alexandra Papadimitriou, et al.
Published: (2020-12-01) -
Stromal Expression of miR-143/145 Promotes Neoangiogenesis in Lung Cancer Development
by: Dimitrova, Ivana Ljubomirova, et al.
Published: (2018) -
Evaluation of miR-143 and miR-145 Expression in Tumors and Tumor Margins in Patients with Colorectal Cancer
by: Shabnam Vardini, et al.
Published: (2017-12-01) -
rs41291957 controls miR‐143 and miR‐145 expression and impacts coronary artery disease risk
by: Ignacio Fernando Hall, et al.
Published: (2021-10-01) -
28S rRNA-Derived Fragments Represent an Independent Molecular Predictor of Short-Term Relapse in Prostate Cancer
by: Marios A. Diamantopoulos, et al.
Published: (2023-12-01)